Latest Product News
Quinten Health Closes its Financing Round To Advance Disease Modeling Platforms and Virtual Twins in Real-World
Quinten Health has announced that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world, as part of the Quinten Group's €14 million growth equity investment.
DAMAN Enters Ambitious European Precision Medicine Healthcare Project
The SQUEEZE project planned to start early 2023 will discover new ways to maximize the impact of prescription drugs for patients suffering from the chronic autoimmune disease Rheumatoid Arthritis.
Molecular Devices and HeartBeat.bio Announce Collaboration To Automate and Scale Cardiac Organoids
Molecular Devices, LLC. and HeartBeat.bio AG, a biotech company developing cardiac organoids for drug discovery, have entered into a co-development agreement.
Peli BioThermal Launches Crēdo™ Go Cold Chain Shipping Solution
Peli BioThermal announces its newest reusable, flexible temperature-controlled shipping solution.
SonALAsense Forges Ahead With First Patient Dosing for Devastating Childhood Brain Cancer
Multisite study will test sonodynamic therapy in pediatric patients with diffuse intrinsic pontine glioma (DIPG).
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis
Waters Corporation today announced expanded powder rheology capabilities for its TA Instruments HR Rheometers allowing scientists to make repeatable powder rheology measurements.
Genome Editing of Immune Cells
On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.
CapnoPharm Awarded as Drug Delivery Platform Capnodrug® Reaches Finals of Reuters Pharma Europe Award 2022
CapnoPharm is proud to announce its selection as a finalist of the prestigious Reuters Pharma Europe Award 2022 for its Cancer drug delivery innovation - Capnodrug® - in the Health Entrepreneur Award category.
PhoreMost Enters Multi-Project Drug Target Discovery Collaboration With Roche
PhoreMost Ltd. today announced it has entered into a multi-project target discovery collaboration with Roche.
Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration
Avacta Group plc announces that the US Food and Drug Administration has granted Orphan Drug Designation to the company’s lead pre|CISION drug candidate, AVA6000, for treatment of soft tissue sarcoma.